Clinic
El Paso Children's Hospital Corporation
El Paso Children's Hospital Corporation was paid $24.42M by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoEL PASO CHILDREN'S HOSPITAL CORPORATION
EL PASO, TX 79905
EL PASO, TX 79905
33aNPI1558659714assigned 07/21/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$24.42M
24GClaims250,219
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Texas
Rank by total paid#3 of 151
Median peer was paid$125K
This provider vs. median196×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,523 | $407K | |
| 2019 | 579 | $220K | |
| 2020 | 3,122 | $334K | |
| 2021 | 44,415 | $3.49M | |
| 2022 | 67,915 | $7.34M | |
| 2023 | 78,206 | $8.01M | |
| 2024incomplete | 52,459 | $4.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 15,826 | 15,441 | $9.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 33,706 | 32,854 | $3.48M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 11% | 5,694 | 5,454 | $2.74M |
| G0378 | Hospital observation service, per hour | 7.7% | 2,744 | 2,535 | $1.88M |
| 87631 | 3.8% | 6,096 | 5,962 | $922K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 3.4% | 889 | 875 | $827K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.9% | 12,944 | 10,432 | $720K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 5,612 | 5,447 | $467K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.6% | 881 | 847 | $383K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.5% | 719 | 668 | $365K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.4% | 3,638 | 3,570 | $351K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,506 | 2,440 | $240K |
136 more codes
| 80053 | Comprehensive metabolic panel | <1% | 15,248 | $228K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,834 | $193K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,786 | $186K |
| 95812 | <1% | 319 | $184K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,696 | $160K |
| 93307 | <1% | 497 | $145K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 49 | $130K |
| 99000 | <1% | 8,506 | $124K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,159 | $118K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 229 | $118K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,078 | $115K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,554 | $112K |
| 74018 | <1% | 2,265 | $87K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,094 | $81K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 680 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,686 | $57K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,407 | $55K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 567 | $53K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 108 | $39K |
| 76770 | <1% | 226 | $38K | |
| 86710 | <1% | 3,533 | $36K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,400 | $36K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 42 | $33K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 7,520 | $32K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 61 | $28K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 130 | $26K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,776 | $25K |
| 81001 | <1% | 6,952 | $24K | |
| 82947 | <1% | 7,046 | $23K | |
| 85046 | <1% | 2,671 | $22K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 582 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 237 | $21K |
| 83735 | <1% | 2,472 | $21K | |
| 80050 | General health panel | <1% | 187 | $19K |
| 74019 | <1% | 358 | $17K | |
| 82728 | <1% | 881 | $17K | |
| 70220 | <1% | 145 | $16K | |
| 84439 | <1% | 950 | $14K | |
| 99001 | <1% | 1,820 | $14K | |
| 84100 | <1% | 2,294 | $13K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 128 | $13K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 917 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,315 | $11K |
| 77072 | <1% | 133 | $9K | |
| 36591 | <1% | 285 | $9K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 4,743 | $8K |
| 96409 | <1% | 77 | $8K | |
| 80061 | Lipid panel | <1% | 369 | $8K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 51 | $7K |
| 82330 | <1% | 503 | $7K | |
| 92567 | <1% | 176 | $7K | |
| 96130 | <1% | 79 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,518 | $7K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 212 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 651 | $5K |
| 84703 | <1% | 681 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 31 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 138 | $4K |
| 86140 | <1% | 689 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 134 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 27 | $4K |
| 96139 | <1% | 44 | $4K | |
| 73090 | <1% | 65 | $4K | |
| 73110 | <1% | 69 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 440 | $3K |
| 87040 | <1% | 245 | $3K | |
| 73080 | <1% | 54 | $3K | |
| 88312 | <1% | 48 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,760 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 28 | $3K |
| 81003 | <1% | 545 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 26 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 26 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 154 | $2K |
| 99201 | <1% | 55 | $2K | |
| 85651 | <1% | 325 | $2K | |
| 99170 | <1% | 16 | $2K | |
| 96137 | <1% | 41 | $2K | |
| 81025 | <1% | 112 | $2K | |
| 84295 | <1% | 427 | $1K | |
| 96136 | <1% | 40 | $1K | |
| 90836 | <1% | 21 | $1K | |
| 84132 | <1% | 422 | $1K | |
| 82435 | <1% | 420 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $1K |
| 83003 | <1% | 58 | $1K | |
| 82670 | <1% | 27 | $1K | |
| 77074 | <1% | 13 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,831 | $1K |
| 87807 | <1% | 87 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 795 | $1K |
| 84145 | <1% | 36 | $1K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 12 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 435 | $968.49 |
| 96138 | <1% | 45 | $947.52 | |
| 82652 | <1% | 32 | $839.06 | |
| 90686 | <1% | 30 | $756.95 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 521 | $734.47 |
| 82784 | <1% | 49 | $646.89 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 457 | $644.57 |
| 83001 | <1% | 24 | $600.01 | |
| 83002 | <1% | 24 | $549.61 | |
| 83516 | <1% | 27 | $512.24 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 181 | $504.63 |
| 87081 | <1% | 70 | $456.78 | |
| 84520 | <1% | 134 | $425.58 | |
| 86803 | <1% | 13 | $423.50 | |
| 86850 | <1% | 27 | $417.78 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 57 | $338.88 |
| 80076 | <1% | 27 | $333.31 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 22 | $323.42 |
| 87340 | <1% | 13 | $306.56 | |
| 85027 | <1% | 37 | $305.33 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 25 | $275.56 |
| 83550 | <1% | 13 | $186.07 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 375 | $163.74 |
| 85014 | <1% | 136 | $131.54 | |
| 86592 | <1% | 13 | $126.79 | |
| 86900 | <1% | 27 | $105.32 | |
| 83690 | <1% | 16 | $103.95 | |
| 86901 | <1% | 27 | $94.36 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 25 | $91.45 |
| 83615 | <1% | 17 | $73.53 | |
| 82247 | <1% | 16 | $70.76 | |
| 85007 | <1% | 13 | $60.30 | |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $49.80 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 78 | $20.37 |
| 36416 | <1% | 165 | $5.42 | |
| A9270 | Non-covered item or service | <1% | 3,152 | $2.89 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 27 | $0.00 |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 0% | 26 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 126 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 252 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTOUT, CINDY (CHIEF EXECUTIVE OFFICER)